Regenative Labs Launches National Research Program to Study Wharton’s Jelly Allografts as an Improved Alternative to More Invasive Procedures
Share Article
New retrospective repository of data on Wharton’s jelly allografts as a structural tissue supplement for cartilage and muscle tears, and other soft tissue voids and defects
“We are calling clinicians from a wide variety of specialties to participate in our study program and believe by following patient outcomes, the real-world data and real-world evidence will bring Wharton’s jelly allografts to the forefront and set the new gold standard in orthopedic pathology.”
PENSACOLA, Fla. (PRWEB)
April 19, 2021
Regenative Labs is now partnering with physicians nationwide in newly launched study programs using Wharton’s jelly allografts for procedures in a variety of specialties. Study partners take advantage of the study program that provides a simple data collection pathway to follow patient outcomes and propel these less invasive allogenic procedures into the future of mainstream medicine.